Registry of Patients Diagnosed With Lysosomal Storage Diseases
Purpose
This is an international prospective and retrospective registry of patients with Lysosomal Storage Diseases (LSDs) to understand the natural history of the disease and the outcomes of fetal therapies, with the overall goal of improving the prenatal management of patients with LSDs.
Conditions
- Mucopolysaccharidosis I
- Mucopolysaccharidosis II
- Mucopolysaccharidosis IV A
- Mucopolysaccharidosis VI
- Mucopolysaccharidosis VII
- Pompe Disease Infantile-Onset
- Neuronopathic Gaucher Disease
- Wolman Disease
Eligibility
- Eligible Ages
- Under 64 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Patients aged 0-64 with a diagnosis of a lysosomal storage disease - Pregnant patients whose fetus has a diagnosis of a lysosomal storage disease
Exclusion Criteria
- There are no current exclusion criteria
Study Design
- Phase
- Study Type
- Observational [Patient Registry]
- Observational Model
- Cohort
- Time Perspective
- Other
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| Mucopolysaccharidosis I | Prenatally or postnatally diagnosed individuals |
|
| Mucopolysaccharidosis II | Prenatally or postnatally diagnosed individuals |
|
| Mucopolysaccharidosis IV A | Prenatally or postnatally diagnosed individuals |
|
| Mucopolysaccharidosis VI | Prenatally or postnatally diagnosed individuals |
|
| Mucopolysaccharidosis VII | Prenatally or postnatally diagnosed individuals |
|
| Infantile-Onset Pompe Disease | Prenatally or postnatally diagnosed individuals |
|
| Neuronopathic Gaucher | Prenatally or postnatally diagnosed individuals |
|
| Wolman Disease | Prenatally or postnatally diagnosed individuals |
|
Recruiting Locations
San Francisco, California 94143
More Details
- NCT ID
- NCT05619900
- Status
- Recruiting
- Sponsor
- University of California, San Francisco
Detailed Description
The need for methods to track patient outcomes, clinical management, medical decision making, and quality of care are all part of current national mandates in patient safety and quality of care delivery. The aim of this registry is to prospectively and retrospectively collect data on patients who are diagnosed with Lysosomal Storage Disease and other LSD mutations. Data collected will be used to: 1. Identify patient outcomes of therapies. 2. Improve clinical management of patients with LSDs. 3. Improve medical decision making. 4. Improve quality of care.